Prostate Embolization for Benign Prostatic Hyperplasia

计划入组 15 人 · 首次发布于 2013 年 8 月 19 日

Saw Palmetto Extract in Benign Prostatic Hyperplasia

计划入组 224 人 · 首次发布于 2002 年 5 月 17 日

Rezum I Pilot Study for Benign Prostatic Hyperplasia

计划入组 50 人 · 首次发布于 2016 年 10 月 24 日

hormone modulator (benign prostate hyperplasia)

Mepartricin

Silodosin(Rapaflo, Silodyx, Urorec, Silodosin Recordati)

C₂₅H₃₂F₃N₃O₄ · Rx

University Of Benin

Nigeria

NEW YORK PROSTATE INSTITUTE

United States

PROSTATE LASER CENTER, PLLC

United States

FDA Approves ProVee System, First Next-Generation Prostatic Urethral Stent for Benign Prostatic Hyperplasia

Modified Water Vapor Therapy Shows Promise for Large-Volume Benign Prostatic Hyperplasia Treatment

Jyong Biotech's BOTRESO® Shows Promising Phase III Results for Benign Prostatic Hyperplasia Treatment